PubMed:15843596
Annnotations
Glycan-Motif
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 27-34 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T2 | 27-34 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T3 | 222-229 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T4 | 222-229 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T5 | 798-805 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T6 | 798-805 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T7 | 850-857 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T8 | 850-857 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T9 | 1030-1037 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T10 | 1030-1037 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T11 | 1324-1331 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T12 | 1324-1331 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 27-34 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
T3 | 222-229 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
T5 | 798-805 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
T7 | 850-857 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
T9 | 1030-1037 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
T11 | 1324-1331 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 27-34 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T2 | 27-34 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T3 | 222-229 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T4 | 222-229 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T5 | 798-805 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T6 | 798-805 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T7 | 850-857 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T8 | 850-857 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T9 | 1030-1037 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T10 | 1030-1037 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T11 | 1324-1331 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T12 | 1324-1331 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-143 | Sentence | denotes | Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase. |
TextSentencer_T2 | 144-319 | Sentence | denotes | An important class of carbohydrates studied within the field of glycobiology, heparin and heparan sulfate (HS) have been implicated in a diverse array of biological functions. |
TextSentencer_T3 | 320-495 | Sentence | denotes | Changes in their sulfation pattern and domain organization have been associated with different pathological situations such as viral infectivity, tumor growth, and metastasis. |
TextSentencer_T4 | 496-809 | Sentence | denotes | To obtain structural information about these biomolecules, and the modifications they may undergo during different stages of cell growth and development, a mass spectrometry-based method was developed and used to obtain unambiguous structural information on the glycosaminoglycans (GAGs) that comprise heparin/HS. |
TextSentencer_T5 | 810-989 | Sentence | denotes | The method was applied to assay for the heparin substrate specificity of a newly discovered human extracellular endosulfatase, HSulf-2, which has been implicated in tumorigenesis. |
TextSentencer_T6 | 990-1085 | Sentence | denotes | This new protocol incorporates 12 known heparin disaccharides, including three sets of isomers. |
TextSentencer_T7 | 1086-1273 | Sentence | denotes | A unique response factor (R) is determined for each disaccharide, whereas a multiplexed and data processing method is incorporated for faster data acquisition and quantification purposes. |
TextSentencer_T8 | 1274-1384 | Sentence | denotes | Proof of principle was performed by using various heparin/HS samples isolated from bovine and porcine tissues. |
T1 | 0-143 | Sentence | denotes | Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase. |
T2 | 144-319 | Sentence | denotes | An important class of carbohydrates studied within the field of glycobiology, heparin and heparan sulfate (HS) have been implicated in a diverse array of biological functions. |
T3 | 320-495 | Sentence | denotes | Changes in their sulfation pattern and domain organization have been associated with different pathological situations such as viral infectivity, tumor growth, and metastasis. |
T4 | 496-809 | Sentence | denotes | To obtain structural information about these biomolecules, and the modifications they may undergo during different stages of cell growth and development, a mass spectrometry-based method was developed and used to obtain unambiguous structural information on the glycosaminoglycans (GAGs) that comprise heparin/HS. |
T5 | 810-989 | Sentence | denotes | The method was applied to assay for the heparin substrate specificity of a newly discovered human extracellular endosulfatase, HSulf-2, which has been implicated in tumorigenesis. |
T6 | 990-1085 | Sentence | denotes | This new protocol incorporates 12 known heparin disaccharides, including three sets of isomers. |
T7 | 1086-1273 | Sentence | denotes | A unique response factor (R) is determined for each disaccharide, whereas a multiplexed and data processing method is incorporated for faster data acquisition and quantification purposes. |
T8 | 1274-1384 | Sentence | denotes | Proof of principle was performed by using various heparin/HS samples isolated from bovine and porcine tissues. |
T1 | 0-143 | Sentence | denotes | Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase. |
T2 | 144-319 | Sentence | denotes | An important class of carbohydrates studied within the field of glycobiology, heparin and heparan sulfate (HS) have been implicated in a diverse array of biological functions. |
T3 | 320-495 | Sentence | denotes | Changes in their sulfation pattern and domain organization have been associated with different pathological situations such as viral infectivity, tumor growth, and metastasis. |
T4 | 496-809 | Sentence | denotes | To obtain structural information about these biomolecules, and the modifications they may undergo during different stages of cell growth and development, a mass spectrometry-based method was developed and used to obtain unambiguous structural information on the glycosaminoglycans (GAGs) that comprise heparin/HS. |
T5 | 810-989 | Sentence | denotes | The method was applied to assay for the heparin substrate specificity of a newly discovered human extracellular endosulfatase, HSulf-2, which has been implicated in tumorigenesis. |
T6 | 990-1085 | Sentence | denotes | This new protocol incorporates 12 known heparin disaccharides, including three sets of isomers. |
T7 | 1086-1273 | Sentence | denotes | A unique response factor (R) is determined for each disaccharide, whereas a multiplexed and data processing method is incorporated for faster data acquisition and quantification purposes. |
T8 | 1274-1384 | Sentence | denotes | Proof of principle was performed by using various heparin/HS samples isolated from bovine and porcine tissues. |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 35-50 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
T2 | 234-249 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
T3 | 251-253 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
T4 | 806-808 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
T5 | 1332-1334 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
ICD10
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 447-464 | http://purl.bioontology.org/ontology/ICD10/B34.9 | denotes | viral infectivity |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 298-318 | http://purl.bioontology.org/ontology/STY/T039 | denotes | biological functions |
T2 | 1162-1173 | http://purl.bioontology.org/ontology/NCBITAXON/1196578 | denotes | multiplexed |
T3 | 1376-1383 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 43-50 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
T2 | 242-249 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
T3 | 337-346 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfation |
T4 | 447-464 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infectivity |
T5 | 472-478 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T6 | 626-632 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T7 | 621-632 | http://purl.obolibrary.org/obo/GO_0016049 | denotes | cell growth |
T8 | 637-648 | http://purl.obolibrary.org/obo/GO_0032502 | denotes | development |
T9 | 687-696 | http://purl.obolibrary.org/obo/GO_0032502 | denotes | developed |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 109-122 | http://purl.obolibrary.org/obo/GO_0005576 | denotes | extracellular |
T2 | 908-921 | http://purl.obolibrary.org/obo/GO_0005576 | denotes | extracellular |
T3 | 621-625 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
UBERON-AE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1376-1383 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
performance-test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 366-378 | http://purl.obolibrary.org/obo/UBERON_0000062 | denotes | organization |
PD-UBERON-AE-B_T2 | 1376-1383 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
GlycoBiology-Motifs
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 27-34 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
T2 | 222-229 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
T3 | 798-805 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
T4 | 850-857 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
T5 | 1030-1037 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
T6 | 1324-1331 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
GlycoBiology-Epitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-GlycoEpitope-B_T1 | 35-50 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
PD-GlycoEpitope-B_T2 | 234-249 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 466-471 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 123-128 | OrganismTaxon | denotes | human | 9606 |
T2 | 902-907 | OrganismTaxon | denotes | human | 9606 |
T3 | 1357-1363 | OrganismTaxon | denotes | bovine | 9913 |
Glycosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 35-50 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
T2 | 234-249 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
T3 | 251-253 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
T4 | 806-808 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
T5 | 1332-1334 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 109-122 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
T2 | 908-921 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 466-471 | Phenotype | denotes | tumor | HP:0002664 |